📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-12 15:57
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
9 announcements match the current filters (relevance ≥ 5).
Paramount Cosmetics Board Approves Up to ₹72 Cr Rights Issue
Paramount Cosmetics India Ltd's board has approved raising funds via a Rights Issue of equity shares (face value ₹10 each) for an aggregate amount not exceeding ₹72 crore. This proposed fundraise is massive compared to the company's existing scale, representing approximately 10.3x its current market capitalization of ₹7 crore and over 3.5x its TTM revenue of ₹20 crore. The detailed terms, issue price, ratio, and record date will be determined subsequently by the newly authorized 'Right Issue Committee'.
Confidence: HIGH
What changedThe Board of Directors approved raising up to ₹72 crore through the issuance of equity shares on a rights basis.
Why it mattersThe fundraise is exceptionally large relative to the company's ₹7 crore market capitalization and ₹20 crore net worth, implying potentially massive equity dilution or major business transformation depending on subscription and use of proceeds.
Approved fundraise size: up to Rs. 72 croreFace value per share: 10/- eachFundraise vs Market Cap: ~1028%Fundraise vs TTM Revenue: ~360%
📅 Short termInvestors will watch for the announcement of the Rights Issue price, issue ratio, and record date to gauge shareholder dilution and pricing discount.
📈 Long termIf successfully executed, an influx of up to ₹72 crore could fundamentally alter the balance sheet of this microcap firm, though capital allocation efficiency remains critical.
⚠ Risk flags
- Severe dilution risk given fundraise size is over 10x current market capitalization
- Execution and subscription risk regarding full take-up of the ₹72 crore issue
- No specific end-use of proceeds disclosed yet
Key Highlights
Board approved a Rights Issue of equity shares up to ₹72 crore
Shares to have a face value of ₹10/- each
Authorized 'Right Issue Committee' to finalize terms, issue ratio, and record date
Fundraise represents ~1,028% of current market cap (₹7 Cr) and ~360% of TTM revenue (₹20 Cr)
👀 What to Watch
Track subsequent filings for the Rights Issue price, entitlement ratio, record date, and clarity on the specific end-use/deployment plans for the ₹72 crore capital.
Paramount Cosmetics Board to Meet on October 12, 2026 to Consider Fundraise Options
Paramount Cosmetics India Ltd has scheduled a Board of Directors meeting on October 12, 2026, to consider and evaluate various fundraising proposals. The options under consideration include Qualified Institutions Placement (QIP), private placement, preferential issue, rights issue, or other permissible modes. Given the company's micro-cap size of Rs 7 crore market capitalization and TTM revenue of Rs 20 crore, any substantial fundraise could lead to significant equity dilution or balance sheet changes. The proposal remains subject to Board, Audit Committee, shareholder, and regulatory approvals.
Confidence: HIGH
What changedThe company announced a formal board meeting to consider multiple potential capital-raising avenues.
Why it mattersFor a company with a market capitalization of just Rs 7 crore and annual revenue around Rs 21 crore, raising capital could significantly alter the equity base, leverage, or growth trajectory depending on the issue quantum.
Board meeting date: October 12, 2026Meeting time: 03:00 P.M. (IST)Company Market Cap: Rs 7 CrTTM Revenue: Rs 20 Cr
📅 Short termTrading sentiment may focus on the outcome of the October 12 meeting regarding dilution size and instrument type.
📈 Long termIf equity capital is raised and successfully deployed into expanding the personal care business, it could help scale revenue beyond the current Rs 20-22 crore plateau.
⚠ Risk flags
- High equity dilution risk for existing minority shareholders given the tiny Rs 7 crore market cap
- Uncertainty around the fundraising quantum, investor demand, and execution mode
Key Highlights
Board meeting scheduled for Monday, October 12, 2026, at 03:00 PM IST
Meeting to evaluate fundraising via QIP, private placement, preferential issue, rights issue, or other modes
Current market capitalization stands at approximately Rs 7 crore with TTM revenue of Rs 20 crore
Fundraising mode, size, and instrument pricing will be determined subject to statutory and shareholder approvals
👀 What to Watch
Track the outcome of the October 12, 2026 board meeting for the specific fundraising mechanism, issue size, pricing, and potential equity dilution details.
Paramount Cosmetics Proposes 680% Hike in Authorized Capital to Rs 39 Cr Ahead of Oct 29 EGM
Paramount Cosmetics India Ltd has issued an Extraordinary General Meeting (EGM) notice scheduled for October 29, 2026. The company is seeking shareholder approval to increase its Authorized Share Capital from Rs 5.00 crore to Rs 39.00 crore (divided into 3.90 crore equity shares of Rs 10 each). This represents a nearly eight-fold expansion in authorized headroom relative to its current market cap of Rs 7 crore and net worth of Rs 20 crore. Remote e-voting is set between October 26 and October 28, 2026, with the cut-off date on October 23, 2026.
Confidence: HIGH
What changedThe company issued an EGM notice to approve increasing its authorized share capital from Rs 5 crore to Rs 39 crore.
Why it mattersA sharp rise in authorized share capital typically precedes a sizeable equity fundraise, preferential issue, or corporate restructuring, which could cause substantial equity dilution given its current Rs 7 crore market cap.
Current Authorized Capital: Rs. 5,00,00,000/-Proposed Authorized Capital: Rs. 39,00,00,000/-Proposed Capital vs Market Cap: ~557%E-voting cut-off date: 23rd October 2026EGM date: 29th October, 2026
📅 Short termE-voting runs from October 26 to October 28, followed by voting results after the October 29 EGM.
📈 Long termIf followed by an actual capital issuance of this scale, it will materially alter the company's capital structure and shareholding base.
⚠ Risk flags
- Potential high equity dilution risk if large capital is subsequently issued
- Purpose of capital increase not detailed in the explanatory statement
Key Highlights
Authorized Share Capital proposed to increase from Rs 5,00,00,000 to Rs 39,00,00,000
Number of equity shares authorized will expand from 50,00,000 to 3,90,00,000 of face value Rs 10 each
EGM to be held via Video Conferencing on Thursday, October 29, 2026 at 03:00 PM IST
Remote e-voting window opens on October 26, 2026 (09:00 AM) and closes on October 28, 2026 (05:00 PM)
Cut-off date for voting entitlement is Friday, October 23, 2026
👀 What to Watch
Track subsequent disclosures on why this authorized capital is being expanded, specifically looking out for potential preferential allotments, rights issues, or acquisitions that could dilute or re-rate equity.
Paramount Cosmetics Proposes Hike in Authorized Capital from Rs 5 Cr to Rs 39 Cr
Paramount Cosmetics India Ltd's Board has approved an increase in its authorized share capital from Rs 5.00 crore to Rs 39.00 crore, divided into 3.90 crore equity shares of Rs 10 each. This nearly eightfold increase in authorized capital requires shareholder approval at an upcoming Extra Ordinary General Meeting (EGM). For a company with a current market cap of Rs 7 crore and annual revenue of ~Rs 20-21 crore, this headroom creation strongly indicates a potential upcoming equity fundraise, preferential issue, or corporate restructuring. The company has not yet detailed specific capital deployment or fundraise instruments.
Confidence: HIGH
What changedThe Board approved an increase in authorized share capital from Rs 5 crore to Rs 39 crore, pending shareholder approval at an EGM.
Why it mattersA substantial jump in authorized equity headroom suggests preparations for a major fundraise, conversion, or equity issuance relative to the company's Rs 7 crore market cap.
Existing Authorized Capital: Rs. 5,00,00,000/-Proposed Authorized Capital: Rs. 39,00,00,000/-Existing Number of Shares: 50,00,000Proposed Number of Shares: 3,90,00,000Face Value per Share: Rs. 10/-
📅 Short termTraders will watch for details of an upcoming EGM notice and potential issuance of warrants or preferential shares.
📈 Long termIf accompanied by growth capital or debt retirement, it could alter the capital structure, though potential equity dilution poses a key consideration.
⚠ Risk flags
- Significant potential equity dilution if newly authorized shares are fully issued
- Lack of stated use of proceeds or fundraise details in the current filing
Key Highlights
Board approved increasing authorized share capital from Rs 5,00,00,000 to Rs 39,00,00,000
Number of authorized equity shares expands from 50,00,000 to 3,90,00,000 of face value Rs 10 each
Proposed authorized capital of Rs 39 crore is significantly larger than current market cap of Rs 7 crore
Consequent alteration of the Memorandum of Association (MOA) subject to EGM approval
👀 What to Watch
Watch for the EGM notice and subsequent board filings detailing the exact mode and purpose of any planned capital raise, preferential issue, or restructuring.
Paramount Cosmetics to Increase Authorized Capital Nearly Eightfold to Rs 39 Cr
Paramount Cosmetics India Ltd announced that its Board of Directors has approved a substantial increase in authorized share capital from Rs 5.00 crore to Rs 39.00 crore, divided into 3.90 crore equity shares of Rs 10 each. The proposed change entails an alteration to the company's Memorandum of Association and is subject to shareholder approval. The company will hold an Extra Ordinary General Meeting on October 29, 2026, via video conferencing to seek shareholder consent. Such a major headroom expansion—nearly 5.5x the company's current market cap of Rs 7 crore—typically signals preparation for a future equity fundraise, preferential allotment, or restructuring.
Confidence: HIGH
What changedBoard approved raising authorized equity capital from Rs 5 crore to Rs 39 crore, pending shareholder approval at the October 29, 2026 EGM.
Why it mattersA sharp rise in authorized capital creates headroom for significant equity issuance or corporate restructuring relative to its small current equity base and market cap of Rs 7 crore.
Existing Authorized Capital: Rs. 5,00,00,000/-Proposed Authorized Capital: Rs. 39,00,00,000/-Proposed Capital vs Market Cap: ~557%EGM Date: October 29, 2026
📅 Short termMarket participants will await the detailed EGM notice and explanatory statement to see if an immediate capital raise or dilution is planned.
📈 Long termIf followed by an equity fundraise or strategic infusion, it could meaningfully alter the capital structure of this microcap business.
⚠ Risk flags
- Potential large equity dilution risk if the newly created share capital headroom is fully utilized
- Uncertainty regarding the specific end-use or structure of the potential fundraise
Key Highlights
Board approved increasing authorized share capital from Rs 5,00,00,000 to Rs 39,00,00,000
Total authorized equity shares to expand from 50,00,000 to 3,90,00,000 shares of Rs 10 each
EGM convened for Thursday, October 29, 2026, to approve the increase and MOA alteration
Appointed CDSL for remote e-voting and CS Abhishek Chhajed as scrutinizer
👀 What to Watch
Track the upcoming EGM notice and subsequent board announcements to identify the specific purpose of the share capital expansion (such as rights issue, preferential issue, or conversion).
Paramount Cosmetics Q1 PAT at ₹0.12 Cr; Proposes ₹50 Cr Annual Related Party Transaction
Paramount Cosmetics reported a net profit of ₹0.12 Cr for Q1 FY27, a recovery from a loss of ₹0.06 Cr in the year-ago period, despite a 28% decline in revenue to ₹3.36 Cr. The board has proposed a massive material related party transaction (RPT) with Paramount Kum Kum Pvt Ltd for up to ₹50 Cr annually starting FY 2027-28. This proposed RPT is approximately 2.38x the company's current TTM revenue of ₹21 Cr. Additionally, the company executed a deed of conveyance for a property sale in Valsad to the same related party.
Confidence: HIGH
What changedThe company returned to profitability in Q1 FY27 and has initiated a massive long-term supply/distribution agreement with a promoter-linked entity starting in 2027.
Why it mattersThe proposed ₹50 Cr annual transaction suggests a potential major shift in the company's business model or a consolidation of promoter-group operations into the listed entity, which could significantly alter its financial profile.
Q1 Revenue: ₹3.36 CrQ1 Net Profit: ₹0.12 CrProposed Annual RPT: ₹50 CrRPT vs TTM Revenue: 238%Market Cap: ₹19 Cr
📅 Short termThe return to profitability is a positive sign, but the stock may remain volatile as investors digest the implications of the large-scale related party transactions and property sale.
📈 Long termIf the ₹50 Cr annual transaction materializes as planned in FY28, it could lead to a substantial re-rating of the company's revenue base, provided margins are protected in the related-party dealings.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Significant related-party transaction (2.4x current revenue)
- Property sale to promoter-group entity
- Micro-cap liquidity and governance risks
Key Highlights
Revenue from operations fell 28.2% YoY to ₹3.36 Cr from ₹4.68 Cr in June 2025.
Net profit turned positive at ₹0.12 Cr for the quarter, compared to a loss of ₹0.06 Cr in the previous year's corresponding quarter.
Proposed a material RPT for sale/purchase of goods worth ₹50 Cr per year for 5 years starting FY 2027-28.
The proposed annual RPT value (₹50 Cr) represents ~238% of the company's current TTM revenue of ₹21 Cr.
Approved a property sale in Umarsadi, Valsad to promoter-group entity Paramount Kum Kum Private Limited.
👀 What to Watch
Investors should closely monitor the upcoming 41st AGM for details on the property sale valuation and the justification for the ₹50 Cr annual related party transaction, which is significantly larger than the company's current scale.
Paramount Cosmetics Q1 PAT Rs 0.12 Cr; Proposes Rs 50 Cr Annual Related Party Transaction
Paramount Cosmetics reported a Q1 FY27 net profit of Rs 0.12 Cr, recovering from a loss of Rs 0.06 Cr in the same quarter last year, despite a 28% YoY decline in revenue to Rs 3.36 Cr. The board has proposed a massive related party transaction (RPT) with Paramount Kum Kum Pvt Ltd for up to Rs 50 Cr annually for five years starting FY 2027-28. This proposed annual RPT value is approximately 2.38x the company's current TTM revenue of Rs 21 Cr. The company also noted a property sale in Valsad to the same promoter-linked entity.
Confidence: HIGH
What changedThe company has transitioned from a quarterly loss to a small profit and has laid the groundwork for a massive scale-up in related party business starting in 2027.
Why it mattersThe proposed RPT is significantly larger than the company's current total revenue and market cap, suggesting a potential structural shift in how the business operates, though it carries high promoter-dependency risks.
Q1 Revenue: Rs 3.36 CrQ1 Net Profit: Rs 0.12 CrProposed Annual RPT Value: Rs 50 CrRPT vs TTM Revenue: ~238%Promoter Stake in Counterparty: 100%
📅 Short termThe return to profitability in Q1 is a positive sign, but the stock may remain volatile as the market digests the implications of the large-scale related party proposal.
📈 Long termIf the Rs 50 Cr annual transaction materializes in FY28, it could lead to a significant re-rating of the company's scale, provided governance and margins are maintained.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- High related-party concentration
- Transaction value exceeds current market cap
- Execution timeline is distant (FY28)
Key Highlights
Q1 FY27 Revenue from operations stood at Rs 3.36 Cr compared to Rs 4.68 Cr in Jun 2025.
Net Profit for the quarter reached Rs 0.12 Cr, up from a loss of Rs 0.06 Cr in the year-ago period.
Proposed Related Party Transaction of Rs 50 Cr per year for 5 years starting FY 2027-28.
The RPT value represents ~238% of the current TTM revenue of Rs 21 Cr.
Deed of Conveyance executed for sale of property in Umarsadi, Valsad to Paramount Kum Kum Pvt Ltd.
👀 What to Watch
Investors should monitor the AGM voting results regarding the Rs 50 Cr annual related party transaction and seek clarity on how this will impact margins and cash flows starting FY28.
Paramount Cosmetics Completes Sale of Valsad Property to Related Party
Paramount Cosmetics India Ltd has finalized the sale of its property located at Umarsadi, Pardi District, Valsad, through a Deed of Conveyance dated August 6, 2026. The transaction was executed with Paramount Kum Kum Private Limited, a related party, following shareholder approval obtained in February 2026. While the transaction value was not disclosed in this filing, the company's small scale (Market Cap Rs 18 Cr, TTM Revenue Rs 21 Cr) makes any asset disposal potentially material to its balance sheet. All formalities were completed by August 7, 2026, and noted by the Board on August 12, 2026.
Confidence: MEDIUM
What changedThe company has officially transferred ownership of its property in Valsad to a related party, completing a process initiated earlier in the year.
Why it mattersFor a micro-cap company with a net worth of Rs 20 Cr, the sale of physical assets is a significant event that could improve liquidity or signal a shift in operational focus, though the lack of disclosed value prevents a full impact assessment.
Deed of Conveyance Date: 06.08.2026Formalities Completion Date: 07.08.2026EGM Approval Date: 13.02.2026Transaction Value: not disclosedMarket Cap: Rs 18 Cr
📅 Short termThe stock may experience volatility as the market processes the asset sale; however, the lack of financial specifics in the announcement may lead to a neutral reaction until the value is known.
📈 Long termAsset monetization can be positive for liquidity, but as a related-party transaction, investors must ensure the sale was conducted at fair market value to protect minority interests.
⚠ Risk flags
- Related-party transaction
- Transaction value not disclosed
- Micro-cap liquidity risk
Key Highlights
Deed of Conveyance signed on August 6, 2026, for the sale of the Valsad property.
Transaction formalities were fully completed by August 7, 2026.
Shareholders previously approved the transaction via a Special Resolution on February 13, 2026.
The buyer is Paramount Kum Kum Private Limited, indicating a related-party transaction.
The Board of Directors officially noted the completion of the sale on August 12, 2026.
👀 What to Watch
Investors should monitor the next quarterly financial statement (September 2026) to identify the transaction value and assess how the proceeds are utilized, specifically if they are used to reduce debt or fund operations.
Paramount Cosmetics Sells Shoolagiri Factory; Possession Handed Over to Buyer
Paramount Cosmetics India Ltd has entered into a sale agreement for its factory land and building located at Shoolagiri and has handed over possession to the buyer. This transaction follows shareholder approval obtained during an Extraordinary General Meeting (EGM) on February 13, 2026. While the company has received an advance, the specific sale consideration was not disclosed in this filing. The buyer is currently in the process of completing registration and transfer formalities.
Confidence: MEDIUM
What changedThe company has moved from a proposal to sell its Shoolagiri factory to executing a sale agreement and handing over physical possession of the property.
Why it mattersFor a micro-cap company with TTM revenue of Rs 21 Cr, the sale of a manufacturing facility is a significant event that could provide a liquidity boost or indicate a shift toward an asset-light business model.
EGM Approval Date: 13.02.2026Market Cap: Rs 18 CrTTM Revenue: Rs 21 CrSale Value: not disclosed
📅 Short termThe stock may see volatile interest as investors speculate on the cash inflow from the sale, though the lack of a specific transaction value limits immediate fundamental re-rating.
📈 Long termThe long-term impact depends on whether the proceeds are used to deleverage (Debt is currently Rs 2 Cr) or reinvested into higher-margin personal care segments.
⚠ Risk flags
- Delayed regulatory disclosure (admitted oversight)
- Lack of transparency regarding the final sale price in the announcement
- Potential impact on manufacturing capacity
Key Highlights
Shareholder approval for the asset sale was obtained on 13.02.2026.
Possession of the Shoolagiri factory land and building has been officially handed over to the buyer.
The company confirmed receipt of an advance payment towards the proposed sale.
The disclosure was made belatedly due to an oversight, as noted in the 03.08.2026 dated letter.
Company market cap stands at a micro-cap level of Rs 18 Cr, making any asset sale potentially material.
👀 What to Watch
Investors should monitor the next quarterly financial results to identify the exact sale consideration and any 'Exceptional Item' gains, which will clarify the impact on the company's Rs 20 Cr net worth.
